Inmunizaciones en cirrosis y trasplante hepático: Puesta al día

Simple item page
dc.coverageDOI: 10.4067/s0034-98872023000400489
dc.creatorCastro, Lorena
dc.creatorCastro, Nidia Fabiola
dc.creatorEndeiza, María Luz
dc.creatorGabrielmezzano,
dc.date2023
dc.date.accessioned2025-11-18T19:55:16Z
dc.date.available2025-11-18T19:55:16Z
dc.description<p>Patients with cirrhosis and liver transplantation (LT) have a higher risk of infections, complications and death. Vaccines have historically been used to prevent and reduce the risk of complications from viral and bacterial infections. The population with cirrhosis and candidates for LT should be evaluated for immunity against the most relevant immuno-preventable infections, update corresponding immunizations according to the national vaccination program, and inoculate the missing vaccines based on these recommendations. In case of not reaching its inoculation prior to LT, in the post-LT period its vaccination status should be updated. All doctors involved in the health care of these patients must have knowledge about this important topic and be aware of the access and free availability for this population through the presentation of a special form incorporated into the National Immunization Program.</p>eng
dc.identifierhttps://investigadores.uandes.cl/en/publications/8f3b7c1b-bd51-4f10-baa1-5f3fb137655e
dc.identifier.urihttps://repositorio.uandes.cl/handle/uandes/59178
dc.languagespa
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourcevol.151 (2023) nr.4 p.489-496
dc.subjectVaccines
dc.subjectFibrosis
dc.subjectLiver Transplantation
dc.subjectSDG 3 - Good Health and Well-being
dc.titleInmunizaciones en cirrosis y trasplante hepático: Puesta al díaspa
dc.titleVaccination for Cirrhosis and Liver Transplant Patientseng
dc.typeReview articleeng
dc.typeArtículo de revisiónspa
Files
Collections
PURE